Long Term Follow-up of a Phase 2 Study Examining Intratumoral G100 Alone and in Combination with Pembrolizumab in Patients with Follicular Lymphoma
Year: 2018
Type: conference-abstract
Source: Blood
Authors: Christopher R Flowers, Carlos Panizo, Iris Isufi, Alex F. Herrera, Craig Okada, Elizabeth H. Cull, Bela Kis, Jorge M. Chaves, Nancy L. Bartlett, Weiyun Ai, Luis de la Cruz-Merino, Locke J. Bryan, Roch Houot, Kim Linton, Javier Briones, Ian Chau, Gottfried R. von Keudell, Hailing Lu, Frank J Hsu, Ahmad S Halwani
Institutions: Emory University, Clinica Universidad de Navarra, Yale University, City Of Hope National Medical Center, City of Hope, Oregon Health & Science University, Prisma Health, Moffitt Cancer Center, Northwest Medical Specialties, Washington University in St. Louis, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Hospital Universitario Virgen Macarena, Augusta University, Centre Hospitalier Universitaire de Rennes, The Christie NHS Foundation Trust, Universitat Autònoma de Barcelona, Hospital de Sant Pau, Royal Marsden NHS Foundation Trust, Huntsman Cancer Institute
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2904066402
